Financials in USD. Standardized financial statements.
A compact view of how Blue Water Vaccines, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue? | $815,371 | $2.52M | $0 | $0 | $0 | $0 |
| Revenue Growth? | -67.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $182,458 | $1.47M | $0 | $0 | $0 | $0 |
| Gross Profit? | $632,913 | $1.06M | $0 | $0 | $0 | $0 |
| Gross Margin? | +77.6% | +41.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses? | $18.31M | $56.07M | $13.48M | $3.42M | $1.62M | $880,232 |
| Operating Income? | -$17.86M | -$56.49M | -$13.48M | -$3.42M | -$1.62M | -$880,232 |
| EBITDA? | -$17.86M | -$56.49M | -$13.48M | -$3.41M | -$1.62M | -$879,659 |
| Income Before Tax | -$14.03M | -$59.74M | -$13.42M | -$3.42M | -$1.60M | -$821,915 |
| Income Tax Expense | -$525 | -$1.05M | -$129,572 | $0 | -$22,603 | -$58,317 |
| Net Income? | -$14.03M | -$58.69M | -$13.29M | -$3.42M | -$1.58M | -$763,598 |
| EPS? | $-16.56 | $-21.45 | $-1.08 | $-0.31 | $-0.14 | $-0.07 |
| Diluted EPS? | $-16.56 | $-21.45 | $-1.08 | $-0.31 | $-0.14 | $-0.07 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality